MONTREAL, QUEBEC -- (MARKET WIRE) -- January 31, 2007 -- Yves Rosconi, President and CEO of Theratechnologies (TSX: TH), told a luncheon audience at the Vancouver Board of Trade earlier today that the evolution of the pharmaceutical industry is creating exciting new opportunities for Canadian biotech companies. He spoke of growing interest on the part of established pharmaceutical companies in smaller, niche markets. Mr. Rosconi said that this trend is strengthening the negotiating hand of biotech companies and giving them more options to develop their businesses.
